Article summary
The European Medicine Agency has published a reflection paper on good manufacturing practice (GMP) which market authorisation holder (MAH) companies need to comply with. The reflection paper aims to explain and clarify the MAH responsibilities outlined in the European Commission’s GMP guide.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial